Variables | Time from onset to the first clinic visits | Time from onset to diagnosis of severe HFMD | Time from onset to the hospitalization of severe HFMD |
---|---|---|---|
Year | |||
 2009 | 2.0(0.0–1.0) | 2.0(1.0–4.0) | 3.0(2.0–3.0) |
 2010 | 1.0(0.0–1.0) | 3.0(2.0–4.0) | 2.0(2.0–3.0) |
 2011 | 0.0(0.0–1.0) | 3.0(2.0–4.0) | 2.0(1.0–3.0) |
 2012 | 0.0(0.0–1.0) | 3.0(2.0–4.0) | 2.0(1.0–4.0) |
 2013 | 0.0(0.0–1.0) | 3.0(2.0–4.0) | 2.0(1.0–3.0) |
 2014 | 0.0(0.0–1.0) | 3.0(2.0–4.0) | 2.0(1.0–3.0) |
 2015 | 0.0(0.0–1.0) | 3.0(2.0–4.0) | 2.0(1.0–3.0) |
District | |||
 South-region | 0.0(0.00–1.00) | 3.0(1.0–4.0) | 2.0(1.0–3.0) |
 Central-region | 1.0(0.0–1.00) | 3.0(2.00–4.0) | 2.00(1.0–4.00) |
 North-region | 0.0(0.0–1.0) | 3.0(2.0–5.0) | 3.00(1.0–4.0) |
Pathogen | |||
 EV71 | 0.0(0.0–1.0) | 3.0(2.0–4.0) | 2.0(1.0–3.0) |
 CVA16 | 0.0(0.0–1.0) | 2.0(1.5–4.0) | 2.0(1.0–3.0) |
 Other enteroviruses | 0.0(0.0–1.0) | 3.0(2.0–4.0) | 2.0(1.0–3.0) |